Skip to content Skip to footer

TI-RADS Explained: Thyroid Ultrasound Scores

Patient Education · Understanding Results

TI-RADS Explained: Thyroid Ultrasound Scores

Thyroid nodules are common, cancer is rare, and the ultrasound scoring system exists to keep most people out of the biopsy chair.

Medically reviewed
Radiology clinicians
ACR-aligned guidance
Patient-first, always
Quick Answer

TI-RADS grades thyroid ultrasound findings from 1 (normal) to 5 (high suspicion); scores of 1–3 usually mean routine or no follow-up, TR-4 earns a fine-needle aspiration biopsy at size thresholds, and TR-5 earns biopsy at smaller thresholds because suspicion is higher. The system exists because the overwhelming majority of thyroid nodules — even some that look odd — are harmless, and unnecessary thyroid surgery carries lifelong consequences.

Why thyroids need a special scale

Half of adults scanned carefully have thyroid nodules; only a small fraction harbor cancer, and much of that cancer behaves indolently. Without a scoring system, either everyone gets biopsied (harm from overdiagnosis and surgery) or no one does (missed cancers). TI-RADS reads the ultrasound's features — composition, echogenicity, margins, calcifications — and converts them into one of five levels with size-based biopsy thresholds.

The practical translation

TR-1 (nothing seen) and TR-2 (benign-appearing): no follow-up usually needed. TR-3 (mildly suspicious): typically a repeat ultrasound in a year or two, biopsy only if the nodule is large (commonly 2.5 cm and up). TR-4: biopsy thresholds sit lower (around 1.5 cm). TR-5: the most suspicious features — biopsy at about 1 cm, with specialist review regardless of size for some patterns.

What the biopsy is like — and what it usually finds

A fine-needle aspiration uses a thin needle, usually no anesthesia, several passes through the neck skin into the nodule; most patients describe it as pressure and a pinch, over in minutes. Results read as benign (the vast majority — annual ultrasound follows), indeterminate (molecular testing exists for the gray zone), suspicious, or malignant (surgery consult). Benign results usually end the drama entirely.

The overdiagnosis conversation, honestly

Thyroid cancer incidence has risen dramatically without matching mortality changes — the signature of overdetection. Guidelines have responded with stricter biopsy thresholds and "active surveillance" options for small papillary cancers in appropriate patients. If your score recommends biopsy, that is still the right answer; if it recommends watching, that too is the evidence speaking, not neglect.

A TI-RADS level on your report?

Ask our team what the usual next step is for your score and size.

Contact SATMED Health

Frequently asked questions about tI-RADS Scores

What does TR-5 mean?

High suspicion — biopsy at a 1 cm threshold and specialist involvement.

Is a TR-3 nodule dangerous?

Almost always not — it earns observation, not intervention.

What are microcalcifications?

Tiny bright specks on ultrasound that raise the TI-RADS level; one feature among several.

Do I need my thyroid removed if cancer is found?

Small, low-risk cancers now often qualify for active surveillance instead of surgery.

How reliable is the biopsy?

Very for benign and malignant reads; the indeterminate middle earns molecular testing.

Will the nodule go away?

Some cystic nodules shrink; solid ones are watched for change, not disappearance.

Our Innovation

How SATMED Health makes contrast imaging safer

If your exam includes contrast, the delivery equipment matters as much as the scanner. SATMED Health engineers the systems behind every injection.

SATJect

Contrast injector systems built for controlled, consistent delivery — the right dose at the right moment, every time.

Learn more →
SATSyringe

Engineered syringes for smooth, low-pressure injections that reduce discomfort and protect the vessel at the IV site.

Learn more →
SATLine

Patient lines and accessories designed for safe, reliable contrast administration from injector to vein.

Learn more →
SATMix

Contrast management solutions that help departments prepare, verify, and track every dose before it reaches a patient.

Learn more →

Explore SATMED Health productsExplore SATCare Calculators

Learn More

Keep reading

More free, clinician-reviewed guides from SATMED Health.

Sources

  1. RadiologyInfo.org (ACR · RSNA · ASRT). Ultrasound-Guided Thyroid Biopsy. Reviewed July 1, 2026.
  2. MedlinePlus (NIH). Ultrasound (Sonogram).
  3. American College of Radiology. ACR Accredited Facilities Database.

Keep learning, keep asking

Browse more free imaging guides or reach out with any question.

Contact SATMED Health

Medical disclaimer: This article is for education only and is not medical advice, diagnosis, or treatment. Always follow the instructions of your imaging facility and your own physician. If you think you are having an emergency, call 911 (or your local emergency number) immediately.

Please note: SATMED Health is not a medical facility. Please contact your physician with specific medical questions or for a referral to a radiologist. To locate an accredited medical imaging provider in your community, search the ACR accredited facilities database. This website does not provide cost information; imaging costs vary by region.

Subscribe for Updates!